Stockreport

Bristol-Myers Squibb stock drops 3% premarket after FDA delays approval deadline for cancer drug [MarketWatch]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Bristol-Myers Squibb stock drops 3% premarket after FDA delays approval deadline for cancer drug Bristol-Myers Squibb Co. BMY, -5.43% shares dropped nearly 3% in Mond [Read more]